- Investing Ideas
- /
- Biotech Breakthroughs
Biotech Breakthroughs
UPDATED May 02, 2024
Companys with strong funding and high growth potential
85 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ICPT | US$19.00 | 0.1% | 19.1% | US$794.7m | US$19.00 | PS2.5x | E42.4% | n/a | Pharmaceuticals & Biotech | ||
PHAR | €10.00 | -4.3% | -9.5% | €604.7m | €22.27 | PS2.6x | E53.0% | n/a | Pharmaceuticals & Biotech | ||
EXAS | US$62.08 | 5.5% | -7.8% | US$11.1b | US$89.48 | PS4.6x | E61.9% | n/a | Pharmaceuticals & Biotech | ||
BEIG.F | US$11.00 | 0% | n/a | US$16.9b | US$18.22 | PS6.9x | E56.6% | n/a | Pharmaceuticals & Biotech | ||
DVAX | US$11.74 | 4.7% | 4.2% | US$1.5b | US$24.67 | PS6.6x | E43.6% | n/a | Pharmaceuticals & Biotech | ||
0QAJ | €1.22 | 2.9% | -59.3% | €117.2m | €4.81 | PS8x | E53.3% | n/a | Pharmaceuticals & Biotech | ||
PHGU.F | €0.95 | 0% | n/a | €605.1m | €2.12 | PS2.7x | E53.0% | n/a | Pharmaceuticals & Biotech | ||
BGNE | US$162.25 | 5.6% | -35.0% | US$16.9b | US$268.40 | PS6.9x | E56.6% | n/a | Pharmaceuticals & Biotech | ||
AMRN | US$0.91 | 4.0% | -34.5% | US$377.2m | US$1.00 | PS1.3x | E59.6% | n/a | Pharmaceuticals & Biotech | ||
VITRS | kr165.80 | -9.0% | -27.9% | kr22.4b | kr231.95 | PS6.4x | E112.2% | 0.6% | Pharmaceuticals & Biotech | ||
AUPH | US$5.17 | 6.2% | -54.4% | US$747.2m | US$10.14 | PS3.9x | E54.1% | n/a | Pharmaceuticals & Biotech | ||
0IDA | US$11.55 | 3.4% | 3.1% | US$1.5b | US$24.31 | PS6.6x | E43.6% | n/a | Pharmaceuticals & Biotech | ||
TRX | UK£0.61 | 0% | 8.7% | UK£43.3m | UK£1.20 | PS1.8x | E133.0% | n/a | Pharmaceuticals & Biotech |